Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Diabetic Peripheral Neuropathic Pain
Clinical Trial
NCT06628908Last updated: 12/5/2025
VRTX
Vertex Pharmaceuticals Incorporated